Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-04

Clinical Trial Update: A Study of Donepezil Hydrochloride in Patients With Dementia Associated With Cerebrovascular Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating donepezil hydrochloride for dementia associated with cerebrovascular disease; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Donepezil hydrochloride (Donepezil hydrochloride)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Dementia Associated With Cerebrovascular Disease | Phase 4 | Status: COMPLETED | Results posted: 2019-10-04